Janus Henderson Group PLC Bio Techne Corp Transaction History

Janus Henderson Group PLC

$182 Billion
Q2 2024

A detailed history of Janus Henderson Group PLC transactions in Bio Techne Corp stock. As of the latest transaction made, Janus Henderson Group PLC holds 1,106,487 shares of TECH stock, worth $86.6 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

1,106,487

Previous 995,824 11.11%

Holding current value

$86.6 Million

Previous $70.1 Million 13.1%

% of portfolio

0.04%

Previous 0.04%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$62.12 - $84.15 $6.87 Million - $9.31 Million	110,663 Added 11.11%	1,106,487 $79.3 Million
Q1 2024 May 15, 2024	BUY	$65.98 - $77.09 $857,146 - $1 Million	12,991 Added 1.32%	995,824 $70.1 Million
Q4 2023 Feb 14, 2024	BUY	$52.83 - $78.22 $36,399 - $53,893	689 Added 0.07%	982,833 $75.8 Million
Q3 2023 Nov 14, 2023	SELL	$67.52 - $89.42 $294,387 - $389,871	-4,360 Reduced 0.44%	982,144 $66.9 Million
Q2 2023 Aug 14, 2023	SELL	$73.76 - $85.98 $221,280 - $257,940	-3,000 Reduced 0.3%	986,504 $80.5 Million
Q1 2023 May 15, 2023	BUY	$71.62 - $86.62 $226,462 - $273,892	3,162 Added 0.32%	989,504 $73.4 Million
Q4 2022 Feb 14, 2023	BUY	$80.67 - $352.29 $59.5 Million - $260 Million	737,179 Added 295.86%	986,342 $81.7 Million
Q3 2022 Nov 14, 2022	SELL	$282.54 - $391.85 $41,815 - $57,993	-148 Reduced 0.06%	249,163 $70.8 Million
Q2 2022 Aug 15, 2022	SELL	$322.67 - $449.65 $7.9 Million - $11 Million	-24,494 Reduced 8.95%	249,311 $86.4 Million
Q1 2022 May 16, 2022	SELL	$353.85 - $487.79 $25.6 Million - $35.3 Million	-72,428 Reduced 20.92%	273,805 $119 Million
Q4 2021 Feb 14, 2022	BUY	$456.15 - $525.06 $2.34 Million - $2.69 Million	5,119 Added 1.5%	346,233 $179 Million
Q3 2021 Nov 16, 2021	SELL	$444.87 - $538.88 $28.7 Million - $34.7 Million	-64,443 Reduced 15.89%	341,114 $165 Million
Q2 2021 Aug 16, 2021	SELL	$387.35 - $450.26 $45.8 Million - $53.2 Million	-118,161 Reduced 22.56%	405,557 $183 Million
Q1 2021 May 17, 2021	SELL	$314.62 - $411.0 $19.2 Million - $25.1 Million	-60,967 Reduced 10.43%	523,718 $200 Million
Q4 2020 Feb 16, 2021	SELL	$246.9 - $321.87 $38.5 Million - $50.3 Million	-156,136 Reduced 21.08%	584,685 $186 Million
Q3 2020 Nov 16, 2020	SELL	$232.22 - $282.96 $23.6 Million - $28.7 Million	-101,516 Reduced 12.05%	740,821 $184 Million
Q2 2020 Aug 14, 2020	SELL	$185.43 - $279.56 $1.42 Million - $2.15 Million	-7,683 Reduced 0.9%	842,337 $222 Million
Q1 2020 May 14, 2020	SELL	$161.17 - $221.51 $59.2 Million - $81.4 Million	-367,475 Reduced 30.18%	850,020 $161 Million
Q4 2019 Feb 18, 2020	SELL	$189.68 - $222.09 $20.1 Million - $23.5 Million	-105,907 Reduced 8.0%	1,217,495 $267 Million
Q3 2019 Nov 14, 2019	SELL	$183.56 - $216.72 $10.6 Million - $12.5 Million	-57,534 Reduced 4.17%	1,323,402 $259 Million
Q2 2019 Jul 31, 2019	SELL	$188.72 - $215.43 $4.53 Million - $5.17 Million	-24,015 Reduced 1.71%	1,380,936 $288 Million
Q1 2019 Apr 30, 2019	SELL	$136.09 - $200.44 $4.85 Million - $7.14 Million	-35,625 Reduced 2.47%	1,404,951 $279 Million
Q4 2018 Feb 06, 2019	BUY	$132.75 - $203.8 $6.33 Million - $9.72 Million	47,689 Added 3.42%	1,440,576 $208 Million
Q3 2018 Nov 09, 2018	SELL	$147.44 - $204.11 $20,641 - $28,575	-140 Reduced 0.01%	1,392,887 $284 Million
Q2 2018 Aug 10, 2018	BUY	$144.9 - $165.58 $11.1 Million - $12.7 Million	76,538 Added 5.81%	1,393,027 $206 Million
Q1 2018 May 14, 2018	BUY	$131.46 - $151.04 $10.7 Million - $12.3 Million	81,110 Added 6.57%	1,316,489 $199 Million
Q4 2017 Feb 09, 2018	BUY	$121.17 - $134.75 $13.5 Million - $15 Million	111,679 Added 9.94%	1,235,379 $160 Million
Q3 2017 Nov 14, 2017	SELL	$113.59 - $123.78 $7.32 Million - $7.97 Million	-64,408 Reduced 5.42%	1,123,700 $0
Q2 2017 Aug 17, 2017	BUY	N/A	1,188,108	1,188,108 $140 Million

Others Institutions Holding TECH

# of Institutions

604

Shares Held

153M

Call Options Held

171K

Put Options Held

56.9K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $3.07B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Account

Janus Henderson Group PLC Bio Techne Corp Transaction History